Home / Sweden / Active Biotech AB (publ)
Active Biotech AB (publ)
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
22 disclosures on record
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
January 19, 2021 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Get the moves on Active Biotech AB (publ) by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 22, 2025 | Guevoura Fund | 1.25% | |
| December 17, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.30% | |
| December 16, 2025 | Guevoura Fund | 2.68% | |
| December 16, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.23% | |
| December 15, 2025 | Guevoura Fund | 2.59% | |
| December 15, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.11% | |
| December 12, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.99% | |
| December 11, 2025 | Guevoura Fund | 2.42% | |
| December 11, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.74% | |
| December 10, 2025 | Guevoura Fund | 2.40% | |
| December 10, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.58% | |
| December 9, 2025 | Guevoura Fund | 2.05% | |
| December 3, 2025 | Guevoura Fund | 1.36% | |
| November 28, 2025 | Guevoura Fund | 0.90% | |
| November 27, 2025 | Guevoura Fund | 0.67% | |
| February 12, 2021 | Guevoura Fund | 0.00% | |
| February 4, 2021 | Guevoura Fund | 0.94% | |
| February 2, 2021 | Guevoura Fund | 0.82% | |
| January 29, 2021 | Guevoura Fund | 1.14% | |
| January 28, 2021 | Guevoura Fund | 0.96% | |
| January 26, 2021 | Guevoura Fund | 0.63% | |
| January 19, 2021 | Guevoura Fund | 0.50% |
Download 22 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
- Elekta AB (publ) 8.91% of the capital sold short
- JM AB 7.61% of the capital sold short
- Bonesupport Holding AB 6.69% of the capital sold short
- Truecaller AB 6.64% of the capital sold short
- Hemnet Group AB (publ) 6.13% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
- Dynavox Group AB 4.58% of the capital sold short
- RaySearch Laboratories AB (publ) 4.36% of the capital sold short
- Aktiebolaget Electrolux 4.32% of the capital sold short
- AAK AB (publ) 4.23% of the capital sold short
- Tobii AB 3.54% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Active Biotech AB (publ), source Finansinspektionen, data as at December 22, 2025, https://www.quivad.com/action/active-biotech-ab-publ